Table 2.

Cox Univariate and multivariate analysis for freedom from progression

	Univariate		Multivariate
Variable	HR (95% CI)	p	HR (95% CI)	p
SUVmax (≥ vs < 11.41)	2.20 (1.37–3.54)	0.001	1.73 (1.06–2.81)	0.03
FIGO Stage
II vs. I	1.28 (0.80–2.06)	0.30	1.07 (0.66–1.73)	0.79
III vs. I	2.83 (1.76–4.55)	<0.0001	1.98 (1.20–3.27)	0.008
IV vs. I	4.75 (1.67–13.5)	0.003	2.30 (0.77–6.88)	0.14
III/IV vs. I/II	2.59 (1.76–3.82)	<0.0001	1.89 (1.26–2.86)	0.002
Lymph Nodes
Pelvic vs. none	1.30 (0.83–2.03)	0.25	1.27 (0.81–2.00)	0.30
Para-aortic vs. none	3.93 (2.47–6.24)	<0.0001	3.03 (1.88–4.88)	<0.0001
Age	1.00 (0.98–1.01)	0.54
Histology (Squamous vs. Non-squamous)	0.99 (0.61–1.59)	0.96